The Problem
The Global COVID-19 Pandemic continues to place serious burdens on healthcare systems and economies in Southeast Asia.
Affordable, accurate, point-of-care diagnostics are a vital tool for effective pandemic management.
With manufacturing scale up, we aim to produce 2 million RDTs per month at a cost of USD1-2 per test.
Following the pandemic, manufacturing solutions can also be pivoted for other regionally important neglected infectious diseases such as dengue, tuberculosis and malaria.
